SCA
TNDM icon

SAC Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

SAC Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,820
Closed -$623K – 937
2014
Q1 		$623K Buy
+2,820
New +$719K ﹤0.01% 1111

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCP
TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAC Capital Advisors's TNDM Position: Q2 2014 in Review

SAC Capital Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2014, closing a stake of 2,820 shares — an estimated $623K sold.

SAC Capital Advisors first reported a position in TNDM in Q1 2014 and held it in 1 quarter. The position peaked at $623K in Q1 2014. 62 funds tracked by Wall St. Rank hold TNDM as of Q2 2014.

  • SAC Capital Advisors reported no remaining Tandem Diabetes Care position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 2,820 Tandem Diabetes Care shares in Q2 2014, an estimated $623K.
  • SAC Capital Advisors first reported a position in Tandem Diabetes Care in Q1 2014 and held it in 1 quarter.
  • SAC Capital Advisors's Tandem Diabetes Care position peaked at $623K in Q1 2014.
  • 62 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.